Chemours
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $1,330,000 | $1,495,000 | $1,615,000 | $1,368,000 |
Gross Profit | 153,000 | 235,000 | 278,000 | 236,000 |
EBITDA | -323,000 | 198,000 | 152,000 | 154,000 |
EBIT | -76,000 | 119,000 | 72,000 | 66,000 |
Net Income | -61,000 | 60,000 | -381,000 | -4,000 |
Net Change In Cash | 1,330,000 | 1,495,000 | 1,615,000 | 1,368,000 |
Free Cash Flow | 92,000 | 105,000 | 50,000 | -196,000 |
Cash | 670,000 | 613,000 | 502,000 | 464,000 |
Basic Shares | 150,550 | 150,238 | 150,238 | 150,410 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $5,808,000 | $5,782,000 | $6,078,000 | $6,831,000 |
Gross Profit | 902,000 | 1,151,000 | 1,306,000 | 1,616,000 |
EBITDA | 332,000 | 692,000 | 197,000 | 1,195,000 |
EBIT | -8,000 | 391,000 | -110,000 | 904,000 |
Net Income | -386,000 | 86,000 | -238,000 | 578,000 |
Net Change In Cash | 5,808,000 | 5,782,000 | 6,078,000 | 6,831,000 |
Cost of Revenue | -215,000 | |||
Free Cash Flow | 51,000 | -993,000 | 186,000 | 447,000 |
Cash | 672,000 | 713,000 | 1,203,000 | 1,102,000 |
Basic Shares | 150,550 | 150,014 | 148,912 | 158,303 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $0.05 |
2025-09-30 | $0.20 |
2025-06-30 | $0.58 |
